SCHEMBL5879426

SCHEMBL5879426

C=CCc1cccc(CC=C)c1OC(=O)OC

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.44
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 2/20 0.44
GABRA1 P14867 1/20 0.43
GABRB2 P47870 1/20 0.43
HSD17B10 Q99714 2/20 0.42
ADRA2C P18825 2/20 0.41
ADRA2A P08913 1/20 0.41
ADRA2B P18089 1/20 0.41
MEN1 O00255 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
MAPT P10636 1/20 0.39
ADRB2 P07550 3/20 0.39
ADRB1 P08588 3/20 0.39
LMNA P02545 2/20 0.39
HTR1A P08908 1/20 0.39
ADRB3 P13945 1/20 0.39
SLC6A2 P23975 1/20 0.39
BDKRB2 P30411 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9771547 0.83 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL11046668 0.79 GABRA1 (0.46) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL11061861 0.79 GABRA1 (0.42) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL7857061 0.78 MAPK1 (0.51) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL24440339 0.76 KDM4E (0.48) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL44672 0.76 GABRA1 (0.48) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL9715056 0.74 KDM4E (0.51) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL14622099 0.74 KDM4E (0.44) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL3689460 0.74 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2
SCHEMBL5461755 0.74 MRGPRX4 (0.49) KDM4EALDH1A1SMN1; SMN2GABRA1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7141684-B2 Diepoxide derivatives of diallyl phenolics PEWS R GARTH 2006-11-28 US disclosed
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics PEWS R G (US) 2005-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050090673-A1 Novel diepoxide derivatives of diallyl phenolics EBP, EED, ESR2 KDM4E 293/4885ALDH1A1 194/4885SMN1; SMN2 4797/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.